Patients taking a glucagon-like peptide-1 (GLP-1) receptor agonist had about one and a half times the risk of developing thyroid cancer compared to similar controls, according to an observational French study.
22 Nov 2022
A 68-year-old man is evaluated during a routine follow-up visit. Medical history is significant for type 2 diabetes mellitus, hyperlipidemia, hypertension, and aortofemoral bypass surgery 2 years ago. Following a physical exam, what is the most appropriate additional treatment?
15 Nov 2022
A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.
8 Nov 2022
A randomized open-label trial in the United Kingdom found that withdrawal of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with advanced chronic kidney disease (CKD) did not affect estimated glomerular filtration rate (eGFR).
8 Nov 2022
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
1 Nov 2022
This column reviews recent recalls, alerts, and approvals.
1 Nov 2022
The meeting's 14 precourses, taking place on April 25 and 26 in San Diego, cover a variety of internal medicine topics and provide learners with an opportunity to earn additional CME and MOC credit.
25 Oct 2022
A U.K. study compared morning versus evening dosing of antihypertensive drugs, a U.S. study looked at optimal dosing in patients with proteinuria, and a trial in Spain tested self-titration in patients with poorly controlled hypertension.
18 Oct 2022
An updated consensus statement from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) addressed social drivers of health, lifestyle modifications, and new drug classes for type 2 diabetes.
4 Oct 2022
While Medicare has added new codes to increase the reimbursement available to primary care practices, they can be difficult to implement and may not align with the integrated flow of a visit.
1 Oct 2022